Faculty Publications

Smith MR, Chen H, Gordon L, Foran J, Kahl B, Advani R, Gascoyne RD, Weller E, Horning SJ

Phase II study of rituximab plus CHOP followed by Y-90-ibritumomab tiuxetan in patients with previously untreated mantle cell lymphoma: An Eastern Cooperative Oncology Group Study (E1499)

J Clin Oncol. 2006 Jun;24(18):422S-422S.

Abstract